179.04
price up icon1.16%   2.06
after-market Dopo l'orario di chiusura: 179.04
loading
Precedente Chiudi:
$176.98
Aprire:
$177.13
Volume 24 ore:
743.14K
Relative Volume:
0.59
Capitalizzazione di mercato:
$19.39B
Reddito:
$9.54B
Utile/perdita netta:
$841.00M
Rapporto P/E:
24.06
EPS:
7.44
Flusso di cassa netto:
$1.02B
1 W Prestazione:
+3.10%
1M Prestazione:
+1.79%
6M Prestazione:
+14.72%
1 anno Prestazione:
+28.96%
Intervallo 1D:
Value
$176.28
$179.84
Intervallo di 1 settimana:
Value
$172.48
$179.84
Portata 52W:
Value
$135.47
$179.99

Quest Diagnostics Inc Stock (DGX) Company Profile

Name
Nome
Quest Diagnostics Inc
Name
Telefono
(973) 520-2700
Name
Indirizzo
500 PLAZA DRIVE, SECAUCUS
Name
Dipendente
56,000
Name
Cinguettio
@QuestDX
Name
Prossima data di guadagno
2025-04-22
Name
Ultimi documenti SEC
Name
DGX's Discussions on Twitter

Confronta DGX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
DGX
Quest Diagnostics Inc
179.04 19.39B 9.54B 841.00M 1.02B 7.44
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
415.33 150.38B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
205.10 137.52B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
526.92 42.00B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
118.91 32.37B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
159.13 25.50B 15.50B 1.33B 2.16B 7.34

Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-02 Iniziato Redburn Atlantic Buy
2025-03-04 Downgrade Citigroup Buy → Neutral
2025-01-06 Aggiornamento Leerink Partners Market Perform → Outperform
2024-12-17 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2024-12-10 Ripresa Jefferies Buy
2024-10-23 Aggiornamento Robert W. Baird Neutral → Outperform
2024-08-28 Ripresa Evercore ISI In-line
2024-07-10 Aggiornamento Citigroup Neutral → Buy
2024-02-26 Iniziato Leerink Partners Market Perform
2024-02-07 Aggiornamento Jefferies Hold → Buy
2024-01-03 Iniziato Barclays Equal Weight
2023-12-12 Aggiornamento BofA Securities Neutral → Buy
2023-06-29 Iniziato Piper Sandler Neutral
2023-05-02 Downgrade BofA Securities Buy → Neutral
2023-04-03 Aggiornamento Citigroup Sell → Neutral
2023-01-23 Iniziato Evercore ISI In-line
2022-11-17 Downgrade Citigroup Neutral → Sell
2022-08-22 Ripresa Morgan Stanley Equal-Weight
2022-04-04 Downgrade Citigroup Buy → Neutral
2022-02-23 Downgrade UBS Buy → Neutral
2022-02-02 Downgrade Jefferies Buy → Hold
2022-01-28 Downgrade Deutsche Bank Buy → Hold
2021-05-04 Aggiornamento UBS Neutral → Buy
2021-03-12 Downgrade Robert W. Baird Outperform → Neutral
2020-10-21 Aggiornamento Argus Hold → Buy
2020-07-29 Aggiornamento KeyBanc Capital Markets Sector Weight → Overweight
2020-07-14 Aggiornamento BofA Securities Neutral → Buy
2020-06-09 Aggiornamento Wells Fargo Underweight → Equal Weight
2020-06-02 Aggiornamento Deutsche Bank Hold → Buy
2020-04-28 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2020-04-27 Aggiornamento Citigroup Neutral → Buy
2020-04-27 Aggiornamento Wolfe Research Underperform → Peer Perform
2020-03-27 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-01-08 Iniziato Wells Fargo Underweight
2020-01-07 Downgrade Barclays Overweight → Equal Weight
2019-12-19 Aggiornamento BofA/Merrill Underperform → Neutral
2019-07-15 Downgrade Goldman Neutral → Sell
2019-04-02 Aggiornamento Jefferies Hold → Buy
2019-03-18 Ripresa Credit Suisse Neutral
2019-01-31 Downgrade Argus Buy → Hold
2019-01-17 Iniziato UBS Neutral
2019-01-03 Downgrade BofA/Merrill Neutral → Underperform
2018-12-03 Downgrade BofA/Merrill Buy → Neutral
2018-11-30 Downgrade Goldman Buy → Neutral
Mostra tutto

Quest Diagnostics Inc Borsa (DGX) Ultime notizie

pulisher
Jun 11, 2025

Quest Diagnostics and University of Texas want to promote more cancer screenings - Mugglehead Magazine

Jun 11, 2025
pulisher
Jun 11, 2025

Fecal Immunochemical Diagnostic Test (FIT) Market Top - openPR.com

Jun 11, 2025
pulisher
Jun 10, 2025

Quest Diagnostics (DGX) Collaborates with MD Anderson for Cancer Risk Test Development | DGX Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Quest Diagnostics New Blood Test Could Transform Early Cancer Detection for 9 Major Cancers - Stock Titan

Jun 10, 2025
pulisher
Jun 10, 2025

Quest Diagnostics Incorporated : The stock forcefully approaches new pivot levels - marketscreener.com

Jun 10, 2025
pulisher
Jun 09, 2025

Quest Diagnostics (DGX) Stock Analysis: Navigating a 5.5% Upside with Strong Revenue Growth - DirectorsTalk Interviews

Jun 09, 2025
pulisher
Jun 03, 2025

Transcript : Quest Diagnostics Incorporated Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 10 - marketscreener.com

Jun 03, 2025
pulisher
Jun 02, 2025

Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term - Yahoo Finance

Jun 02, 2025
pulisher
May 30, 2025

Here's How Much You Would Have Made Owning Quest Diagnostics Stock In The Last 5 Years - Benzinga

May 30, 2025
pulisher
May 28, 2025

Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

May 28, 2025
pulisher
May 27, 2025

Quest Diagnostics (DGX) Participates in Upcoming Oppenheimer Meeting | DGX Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

HOLX vs. DGX: Which Women's Health-Focused Stock Is the Better Pick? - The Globe and Mail

May 27, 2025
pulisher
May 23, 2025

Is Wall Street Bullish or Bearish on Quest Diagnostics Stock? - inkl

May 23, 2025
pulisher
May 23, 2025

Is Wall Street Bullish Or Bearish On Quest Diagnostics Stock? - Barchart.com

May 23, 2025
pulisher
May 22, 2025

Quest Diagnostics' $4M Rest Break Settlement Gets Initial OK - Law360

May 22, 2025
pulisher
May 22, 2025

Quest Diagnostics (DGX) Announces Results of 2025 Annual Meeting of Stockholders - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Quest Diagnostics Inc (DGX) Shares Gap Down to $171.44 on May 21 - GuruFocus

May 22, 2025
pulisher
May 21, 2025

What's Driving Quest Diagnostics Stock's 25.6% Rally in a Year? - Yahoo Finance

May 21, 2025
pulisher
May 20, 2025

Quest Diagnostics stock hits all-time high of $179.37 By Investing.com - Investing.com Nigeria

May 20, 2025
pulisher
May 19, 2025

Director Diaz Luis was granted 1,203 shares, increasing direct ownership by 42% to 4,054 units (SEC Form 4) - Quantisnow

May 19, 2025
pulisher
May 16, 2025

Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference - PR Newswire

May 16, 2025
pulisher
May 16, 2025

Lung Cancer Diagnostics Market Outlook: Opportunities in Early - openPR.com

May 16, 2025
pulisher
May 16, 2025

Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock - Yahoo Finance

May 16, 2025
pulisher
May 15, 2025

Here's Why Quest Diagnostics (DGX) is a Strong Value Stock - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Insider Sell: Mark Delaney Sells Shares of Quest Diagnostics Inc (DGX) - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Quest Diagnostics Keeps Dividend at $0.80 per Share, Payable July 21 to Shareholders as of July 7 - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Quest Diagnostics (DGX) Declares Consistent Dividend - GuruFocus

May 15, 2025
pulisher
May 14, 2025

Quest Diagnostics Declares Quarterly Cash Dividend - PR Newswire

May 14, 2025
pulisher
May 14, 2025

Quest Diagnostics : Forbes Names Quest Diagnostics One of America's Best Large Employers - marketscreener.com

May 14, 2025
pulisher
May 13, 2025

Is Quest Diagnostics Incorporated's (NYSE:DGX) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - Yahoo

May 13, 2025
pulisher
May 13, 2025

Should You Continue to Retain DGX Stock in Your Portfolio? - TradingView

May 13, 2025
pulisher
May 13, 2025

Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds - Quantisnow

May 13, 2025
pulisher
May 11, 2025

DGX Q1 Earnings Call: Acquisitions, Advanced Diagnostics, and Operational Initiatives Drive Growth - Yahoo Finance

May 11, 2025
pulisher
May 08, 2025

Global Immunodiagnostics Market to Cross the USD 32 Billion by 2032 | DelveInsight - GlobeNewswire Inc.

May 08, 2025
pulisher
May 06, 2025

Quest Diagnostics (DGX) Sees Raised Target Price by JP Morgan | - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga

May 06, 2025
pulisher
May 06, 2025

Quest Diagnostics (DGX) Receives Price Target Increase from JPMo - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Take the Zacks Approach to Beat the Markets: ADMA Biologics, Limbach, Quest Diagnostics in Focus - MSN

May 06, 2025
pulisher
May 03, 2025

Quest Diagnostics Stock: A Leader But Waiting For Better Price (NYSE:DGX) - Seeking Alpha

May 03, 2025
pulisher
May 02, 2025

Quest Settles Fired Black Phlebotomist's Retaliation Suit - Law360

May 02, 2025
pulisher
May 01, 2025

Bullish on Quest Diagnosis Inc. - The Globe and Mail

May 01, 2025
pulisher
Apr 30, 2025

This Company Extended Its Post-Earnings Rally to Record Highs - The Globe and Mail

Apr 30, 2025
pulisher
Apr 29, 2025

Labcorp beats quarterly profit estimate on diagnostic test demand - Reuters

Apr 29, 2025
pulisher
Apr 28, 2025

Fitch elevates Quest Diagnostics’ rating to ’BBB+’ with stable outlook By Investing.com - Investing.com Canada

Apr 28, 2025
pulisher
Apr 28, 2025

Fitch elevates Quest Diagnostics’ rating to ’BBB+’ with stable outlook - Investing.com

Apr 28, 2025
pulisher
Apr 28, 2025

Piper Sandler Adjusts Price Target on Quest Diagnostics to $200 From $180, Maintains Neutral Rating - marketscreener.com

Apr 28, 2025
pulisher
Apr 26, 2025

Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insight - GuruFocus

Apr 26, 2025

Quest Diagnostics Inc Azioni (DGX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research WAT
$349.57
price up icon 1.02%
diagnostics_research LH
$261.65
price up icon 0.65%
$164.35
price down icon 1.45%
diagnostics_research MTD
$1,188.21
price down icon 0.40%
diagnostics_research IQV
$159.13
price up icon 0.19%
Capitalizzazione:     |  Volume (24 ore):